Evidence map›Paper›PMID 26415497›Full record

ReviewBioscience reports2015

Animal models for photodynamic therapy (PDT).

Zenildo Santos Silva, Sandra Kalil Bussadori, Kristianne Porta Santos Fernandes, Ying-Ying Huang, Michael R Hamblin

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Bioscience reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06731881 (Leveraging Photodynamic Therapy to Inhibit Microorganisms - Assessing the Efficacy of Photodynamic Therapy for Preventing Surgical Site Infections in Nasal Surgery Patients), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06731881 narecruitingnot on this mapstarted 2025, after this paper: background citation

Leveraging Photodynamic Therapy to Inhibit Microorganisms - Assessing the Efficacy of Photodynamic Therapy for Preventing Surgical Site Infections in Nasal Surgery Patients: A Pilot Study

TypeinterventionalSponsorGuy's and St Thomas' NHS Foundation TrustRan2025 to 2026Enrolled80ConditionsSurgery, Nasal Disease, Light, Therapy, ComplicationsArmsNasal PDT, Photosensitizer formulation only, Standard follow-up, Nasal culture, Flexible nasendoscopy
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Application of Photodynamic Therapy in Cardiology.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Tetracyclines: light-activated antibiotics?Future medicinal chemistry · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zenildo Santos SilvaMassachusetts General Hospital, Wellman Center for Photomedicine, Boston, MA 02114, U.S.A. Harvard Medical School, Department of Dermatology, Boston, MA 02114, U.S.A. Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, São Paulo, SP 02117-010, Brazil.
Sandra Kalil BussadoriPostgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, São Paulo, SP 02117-010, Brazil.
Kristianne Porta Santos FernandesPostgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, São Paulo, SP 02117-010, Brazil.
Ying-Ying HuangMassachusetts General Hospital, Wellman Center for Photomedicine, Boston, MA 02114, U.S.A. Harvard Medical School, Department of Dermatology, Boston, MA 02114, U.S.A.
Michael R HamblinMassachusetts General Hospital, Wellman Center for Photomedicine, Boston, MA 02114, U.S.A. Harvard Medical School, Department of Dermatology, Boston, MA 02114, U.S.A. Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, U.S.A. hamblin@helix.mgh.harvard.edu.
Universidade Nove de Julho · BR

Funding

Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
NIAID NIH HHS R01AI050875
6 · The paper itself

Abstract

Photodynamic therapy (PDT) employs non-toxic dyes called photosensitizers (PSs), which absorb visible light to give the excited singlet state, followed by the long-lived triplet state that can undergo photochemistry. In the presence of ambient oxygen, reactive oxygen species (ROS), such as singlet oxygen and hydroxyl radicals are formed that are able to kill cancer cells, inactivate microbial pathogens and destroy unwanted tissue. Although there are already several clinically approved PSs for various disease indications, many studies around the world are using animal models to investigate the further utility of PDT. The present review will cover the main groups of animal models that have been described in the literature. Cancer comprises the single biggest group of models including syngeneic mouse/rat tumours that can either be subcutaneous or orthotopic and allow the study of anti-tumour immune response; human tumours that need to be implanted in immunosuppressed hosts; carcinogen-induced tumours; and mice that have been genetically engineered to develop cancer (often by pathways similar to those in patients). Infections are the second biggest class of animal models and the anatomical sites include wounds, burns, oral cavity, ears, eyes, nose etc. Responsible pathogens can include Gram-positive and Gram-negative bacteria, fungi, viruses and parasites. A smaller and diverse group of miscellaneous animal models have been reported that allow PDT to be tested in ophthalmology, atherosclerosis, atrial fibrillation, dermatology and wound healing. Successful studies using animal models of PDT are blazing the trail for tomorrow's clinical approvals.

Indexed as

PhotochemotherapyAnimalsDisease Models, AnimalHumansMiceNeoplasmsRatsReactive Oxygen SpeciesReactive Oxygen Speciesautochthonouscancergenetically-engineered mouse modelinfectionorthotopic tumourphotodynamic therapysubcutaneous tumourxenograft

Identifiers

PMID26415497
PMCPMC4643327
OpenAlexW1553180237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.